Reconstitution of synaptic vesicle formation in vitro has revealed a pathway of synaptic vesicle biogenesis from endosomes that requires the heterotetrameric adaptor complex AP3. Because synaptic vesicles have a distinct protein composition, the AP3 complex should selectively recognize some or all of the synaptic vesicle proteins. Here we show that one element of this recognition process is the v-SNARE, VAMP-2, because tetanus toxin, which cleaves VAMP-2, inhibited the formation of synaptic vesicles and their coating with AP3 in vitro. Mutant tetanus toxin and botulinum toxins, which cleave t-SNAREs, did not inhibit synaptic vesicle production. AP3-containing complexes isolated from coated vesicles could be immunoprecipitated by a VAMP-2 antibody. These data imply that AP3 recognizes a component of the fusion machinery, which may prevent the production of inert synaptic vesicles.
CT reveals more subchondral fractures in osteonecrosis of the femoral head than unenhanced radiography or MR imaging. The high-signal-intensity line seen on T2-weighted MR images appears to represent fluid accumulating in the subchondral fracture, which may indicate a breach in the overlying articular cartilage.
Mediatophore is a protein of "200 kDa able to translocate acetylcholine in response to calcium. It was purified from the presynaptic plasma membranes of the electric organ nerve terminals. Mediatophore is a homooligomer of a 16-kDa subunit, homologous to the proteolipid of V-ATPase. Cells of the N18TG-2 neuronal line are not able to produce quantal acetylcholine release. We show here that transfection of N18TG-2 cells with a plasmid encoding the mediatophore subunit restored calcium-dependent release. The essential feature of such a release was its quantal nature, similar to what is observed in situ in cholinergic synapses from which mediatophore was purified.We have previously purified from the nerve terminal membranes of Torpedo electric organ a protein of "200 kDa able to translocate acetylcholine (AcCh) upon the action of calcium (1, 2). The protein, named mediatophore, was localized at the active zones (3) and shown to be a homooligomer of a 16-kDa subunit. The sequence of the subunit was found to be homologous to the proteolipid present in the membrane sector of the V ATPase (4, 5) and also in gap junction proteins (6). An antisense probe to the 16-kDa messenger selectively inhibited expression of the 16-kDa mediatophore subunit and suppressed AcCh release from Xenopus oocytes that were rendered able to synthesize and release AcCh after being injected with electric lobe mRNAs (7,8). These experiments together with pharmacological, morphological, and biochemical observations suggested that mediatophore might indeed be involved in the final step of release-i.e., the translocation of AcCh through the nerve terminal plasma membrane (9, 10). The protein would form a pore, switched on by calcium and capable of releasing AcCh either from the cytoplasm or from vesicular stores (fusion pore). It was therefore crucial to determine whether mediatophore would by itself render cells able to release AcCh and whether such a release would display quantal properties as is the case for physiological transmission of nerve impulses.Experiments along this line were difficult to plan, because the 16-kDa mediatophore subunit is also found in the VATPase, which is involved in storage processes, including the storage of AcCh in vesicles. Indeed, the vesicular AcCh transporter carries the transmitter in exchange to protons accumulated by V-ATPase (11, 12). The problem was simplified when we found that the NG108-15 cells, which result from fusion of N18TG-2 and C6BU-1 cells, had high levels of the 16-kDa protein in their membrane. The 16-kDa protein is also abundant in the membranes of C6BU-1 cells but very low in those of N18TG-2 cells (13). It was also found that NG108-15 and C6BU-1 cells release AcCh after being loaded with transmitter, while N18TG-2 cells were unable to release (13,14). In parallel work (15), the same cell types were transfected with a plasmid encoding choline acetyltransferase and were studied in coculture with myocytes. As synapses were formed, miniature end-plate potentials were recorded from NG108-15...
The assembly of multimeric protein complexes that include vesicle-associated membrane protein 2 (VAMP-2) and the plasma membrane proteins syntaxin 1A and synaptosomeassociated protein of 25 kDa (SNAP-25) are thought to reflect the biochemical correlates of synaptic vesicle targeting, priming, or fusion. Using a variety of protein-protein interaction assays and a series of deletion and point mutations, we have investigated the domains of VAMP-2 required for the formation of binary complexes with either syntaxin 1A or SNAP-25 and ternary complexes with both syntaxin 1A and SNAP-25. Deletions within the central conserved domain of VAMP-2 eliminated binding to either syntaxin 1A or both syntaxin 1A and SNAP-25. Although all of the deletion mutants were able to form ternary complexes, only some of these complexes were resistant to denaturation in sodium dodecyl sulfate. These results demonstrate that cooperative interactions result in the formation of at least two biochemically distinct classes of ternary complex. Two point mutations previously shown to have effects on the intracellular trafficking of VAMP-2 (M46A, reduced endocytosis and sorting to synaptic vesicles; N49A, enhanced sorting to synaptic vesicles) lie within a domain required for both syntaxin 1A and SNAP-25 binding. Syntaxin 1A and SNAP-25 binding was reduced by the M46A mutation and enhanced by the N49A mutation, suggesting that a correlation exists between the membrane-trafficking phenotype of the two VAMP-2 point mutants and their competence to form complexes with either syntaxin 1A or SNAP-25.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.